Effect of linseed oil in the treatment of carpal tunnel syndrome

Not Applicable

• Conditions: Carpal tunnel syndrome.; Carpal tunnel syndrome

• Registration Number: IRCT2012103111341N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Inclusion criteria: primary idiopathic carpal tunnel syndrome; patients aged between 18-65 years old; electrodiagnostic criteria for mild or moderate CTS; Patient's written informed consent for inclusion; having at least two signs or one sign plus one symptom of: paresthesias, numbness, tingling, night pain
positive Phalen test, positive Tinnel test, positive compression test.
Exclusion criteria: Clinical and electrodiagnostic evidence of severe CTS including muscular atrophy and neurogenic changes in needle EMG of APB muscle; recurrent carpal tunnel syndrome; Positive history of trauma and/or fracture of wrist bones and/or surgical release of median nerve and/or direct injection into carpal tunnel of wrist; Evidence of cervical radiculopathy in EMG; Systemic disease including: neuropathies (rule out by nerve conduction study of ulnar nerves) and/or collagen vascular diseases such as SLE and scleroderma and RA; Endocrine diseases such as hypothyroidism and DM; Other
disease-inducing neuropathy; Situations such as renal failure and/or alcoholism and/or poor medical condition; History of recent and ongoing use of corticosteroids or analgesics that could not be discontinued; hypersensitivity to the drug or placebo; inability to completion of data gathering forms (cognitive or language disorder).

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Median nerve wrist sensory nerve conduction velocity. Timepoint: beginning of the study and after 4 weeks. Method of measurement: electrodiagnosis.;Median nerve motor distal latency. Timepoint: beginning of the study and after 4 weeks. Method of measurement: electrodiagnosis.;Median nerve sensory distal latency. Timepoint: beginning of the study and after 4 weeks. Method of measurement: electrodiagnosis.;Median nerve compound latency. Timepoint: beginning of the study and after 4 weeks. Method of measurement: electrodiagnosis.;Boston Carpal Tunnel Questionnaire score. Timepoint: beginning of the study and after 4 weeks. Method of measurement: Boston Carpal Tunnel Questionnaire.